Currently out of the existing stock ratings of Brian Wright, 23 are a BUY (88.46%), 3 are a HOLD (11.54%).

Brian Wright

Work Performance Price Targets & Ratings Chart

Analyst Brian Wright, carries an average stock price target met ratio of 43.33% that have a potential upside of 21.59% achieved within 228 days.

Brian Wright’s has documented 51 price targets and ratings displayed on 11 stocks. The coverage was on Basic Materials, Industrials, Consumer Defensive, Healthcare sectors.

Most recent stock forecast was given on BIOX, Bioceres Crop Solutions Corp at 09-Feb-2024.

Wall Street Analyst Brian Wright

Analyst best performing recommendations are on LNN (LINDSAY).
The best stock recommendation documented was for LNN (LINDSAY) at 8/1/2022. The price target of $160 was fulfilled within 11 days with a profit of $6.61 (4.31%) receiving and performance score of 3.92.

Average potential price target upside

of $15.57 (32.75%) on CTVA (CORTEVA).
of $10.9 (8.38%) on LNN (LINDSAY).
of $6.03 (44.57%) on PAHC (PHIBRO ANIMAL HEALTH).

CTVA Corteva LNN Lindsay EVGN Evogene LOCL Local Bounti Corp ANDE The Andersons BIOX Bioceres Crop Solutions Corp PAHC Phibro Animal Health XXII 22nd Century Group ADM Archer-Daniels-Midland Company BG Bunge MOH Molina Healthcare

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Aleksey Yefremov (KEYBANK)